Guidelines for Acquisition, Interpretation, and Reporting of Whole-Body MRI in Myeloma: Myeloma Response Assessment and Diagnosis System (MY-RADS).
Loading...
Embargo End Date
Authors
Messiou, C
Hillengass, J
Delorme, S
Lecouvet, FE
Moulopoulos, LA
Collins, DJ
Blackledge, MD
Abildgaard, N
Østergaard, B
Schlemmer, H-P
Landgren, O
Asmussen, JT
Kaiser, MF
Padhani, A
Hillengass, J
Delorme, S
Lecouvet, FE
Moulopoulos, LA
Collins, DJ
Blackledge, MD
Abildgaard, N
Østergaard, B
Schlemmer, H-P
Landgren, O
Asmussen, JT
Kaiser, MF
Padhani, A
Document Type
Journal Article
Date
2019-04-01
Date Accepted
Abstract
Acknowledging the increasingly important role of whole-body MRI for directing patient care in myeloma, a multidisciplinary, international, and expert panel of radiologists, medical physicists, and hematologists with specific expertise in whole-body MRI in myeloma convened to discuss the technical performance standards, merits, and limitations of currently available imaging methods. Following guidance from the International Myeloma Working Group and the National Institute for Clinical Excellence in the United Kingdom, the Myeloma Response Assessment and Diagnosis System (or MY-RADS) imaging recommendations are designed to promote standardization and diminish variations in the acquisition, interpretation, and reporting of whole-body MRI in myeloma and allow response assessment. This consensus proposes a core clinical protocol for whole-body MRI and an extended protocol for advanced assessments. Published under a CC BY 4.0 license. Online supplemental material is available for this article.
Citation
Radiology, 2019, 291 (1), pp. 5 - 13
Source Title
Publisher
RADIOLOGICAL SOC NORTH AMERICA
ISSN
0033-8419
eISSN
1527-1315
Collections
Research Team
Myeloma Group
Computational Imaging
Computational Imaging